

Showing 1 - 20 of 148 results


ANSTO Synroc® Treatment Facility
ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.

Role at ANSTO
Australia completes first phase of its waste repatriation project

Sydney Access Proposals
View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.
Silicon irradiation
ANSTO is one of the world's leading providers of irradiation services for silicon ingots, which are used by the multimillion dollar electronics industry across Europe and Asia. Each year, ANSTO irradiates more than 50 tonnes of silicon.
Cancer drug development to be turbocharged as ACRF funding brings ‘broadband’ protein analysis to Australia
Success in ARC Grants

Role at ANSTO:

Pipeline Accelerator Voucher Scheme
Voucher scheme accelerating medical research
Cross collaboration on highly competitive funding for projects and facilities
Excavation of dark matter lab completed
With all excavation completed and rock removed from the underground site, the physics lab will now be built within the caverns of the Stawell Mines site.
Investigating the impact of radiation and radioactive contamination on forensic trace evidence
An unambiguous message of support for carbon capture: a new ARC Centre of Excellence
The ARC Centre of Excellence (CoE) for Green Electrochemical Transformation of Carbon Dioxide, GETCO2, will support innovative approaches to carbon capture.

Energy use and emissions
Detailed data on ANSTO electricity use and CO2 emissions for FY2022 - FY2023

Aerosol Sampling Program
ANSTO plays a leading role in measuring and characterising fine particles from a range of locations around Australia and internationally.
ANSTO is helping construct Australia’s first dark matter lab
Launch of the second phase of construction of the underground laboratory to detect dark matter.

Role at ANSTO
New anti-cancer drugs put cancers to sleep… permanently
Biochemical and structural studies to elucidate protein interactions of the new compounds and target molecules included X-ray diffraction at the Australian Synchrotron.

The Australian Synchrotron
A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.